Foghorn Therapeutics Inc.
Foghorn Therapeutics is a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression. They focus on modulating the chromatin regulatory system to orchestrate gene expression. Their lead product candidate is currently in clinical development, with almost 10 programs in development across a wide range of cancers. Foghorn aims to transform the lives of people with a wide spectrum of diseases.
Offizielles Register
KI-Qualitätsanalyse
Vertrauensscore-Details
Schnellzugriff
Website-Highlights
🌟 Ähnliche vertrauenswürdige Unternehmen
Protalix BioTherapeutics, Inc.
Protalix is dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with their ProCellEx® plant cell-based expression system. They focus on treating rare diseases and have already launched two enzyme replacement therapies. The company is known for its innovative ProCellEx® technology.
Immunocore Holdings plc
Immunocore Holdings plc pioneers TCR therapy, aiming to improve outcomes for patients with cancer, infectious, and autoimmune diseases. They develop transformative immunomodulating medicines using their ImmTAX technology. This technology activates the immune system to recognize and destroy diseased cells.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
PacBio provides advanced DNA sequencing solutions, including Revio, Vega, and Onso systems. They are known for their HiFi long-read and SBB short-read technologies, used in research across human, plant, and microbial genomics. The company is positioned as a leading provider for precise and comprehensive genetic analysis.